Close Menu

Taking on H5N1

NIH announced that a vaccine for H5N1 avian flu designed by scientists at the National Institute of Allergy and Infectious Diseases has entered clinical trials. The DNA-based vaccine is the first to start human trials, according to NIH. If all goes well with this vaccine, it could help pave the way for development of other DNA-based, rather than virus-based, vaccines.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.